Since establishing a partnership to improve patient care, outcomes and safety in 2016, Philips and Masimo have already introduced a variety of advanced monitoring capabilities to select IntelliVue® MX-series multi-parameter monitors. We look forward to continuing our partnership with a focus on improving patient outcomes and reducing the cost of care.” "We are proud that Philips has chosen to make our innovative SedLine, O3, and NomoLine technologies available to their customers. “Combining our expertise in noninvasive monitoring and signal processing technologies with Philips’ expertise in integrated patient monitoring and therapy solutions is a win-win for patients and clinicians alike," said Jon Coleman, President of Worldwide OEM Sales and Global Health, Masimo. “We’re connecting data and technologies to help arm care providers with the robust information they need to make timely, informed care decisions for their patients.” “Our work with Masimo has enabled us to forge new paths in continuous monitoring,” said Christoph Pedain, General Manager, Hospital Patient Monitoring at Philips. These capabilities and metrics help care providers to act decisively while also helping to lower cost of care by providing a more holistic view of the patient from one system. The data can also be shared between monitors.
WEARABLE HEART MONITOR SERIES
Integrating the SedLine, O3® and CO₂ advanced Masimo measurements into Philips high acuity IntelliVue® MX series multi-parameter monitors can help clinicians assess and monitor blood saturation in the brain (cerebral oxygenation), anesthetic sedation, and patient respiratory performance with ease, all from the same monitor. The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment.
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, today announced FDA clearance allowing the activation of SedLine® Brain Function Monitoring, Regional Oximetry (O3®), and CO₂ measurements in Philips Patient Monitors – IntelliVue MX750 and MX850. Amsterdam, the Netherlands and Irvine, California, U.S.
0 kommentar(er)
